Submit Deal
All corporates
Similar corporates
Deals Overview
Market Context
Deals
Service Providers
Relationships
Portfolio (2)
Team
Sort
cerevel therapeutics
HQ - United States
Biotechnology
Pharmaceuticals
28 Oct 2020
Investment Date
£ 1.00 B
Deal Value
1 Aug 2024
100%
Stake
£ 6.89 B
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All Corporates
Back to top
All rights reserved. Copyright © 2025 Datasite
Senior Management
Ronald Renaud
CEO
Kathy Yi
CFO
Susan Altschuller